HOUSTON, TX / ACCESSWIRE / December 4, 2018 / Controversial or not, it’s tough to overlook the growth of the cannabis industry.
By 2025, the global legal marijuana market is expected to reach $146.6 billion, according to Grand View Research Inc. All thanks to fast-paced legalization around the globe.
Canada just recently legalized its use throughout the country. Three more U.S. states just approved its recreational and, or medicinal use. There are now 33 U.S. states that have legalized marijuana in some way. Recreational marijuana is now legal in 10, including Washington, D.C.
Very quickly, legal marijuana is gaining traction worldwide thanks to high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. In addition, we’re just beginning to see a considerable amount of public and private investment for research and development of cannabis products for us in oils, vapes, and other edibles.
We’re even seeing international demand pick up momentum.
For example, Colombia is on its way to become one of the largest global export leaders in medical marijuana since legislation in the region passed in. At current pace, Colombia could supply 44% of the global demand for medical cannabis, as noted by Andres Lopez, the director of Colombia’s National Drug Fund, as quoted by Medical Marijuana Inc.
One of the companies benefiting from surging growth amidst the marijuana boom and in Colombia is Orion Nutraceuticals (CSE:ORI), which is on its way to becoming a global leader in the production of medical and recreational cannabinoid extracts and oils, nutraceuticals and pharmaceuticals.
In addition, along with its network of sports medicine experts, the company is creating a line of sports medicine, CBD based, products. Its target market is athletes, athletic therapists, sports medicine retailers, homeopathic and pharmaceutical companies, manufacturers, distributors, wholesalers, consumers and retailers.
For More Information on Orion Nutraceuticals, Click Here.
That gives the company exposure to the cannabidiol (CBD) market, which is projected to grow as much as 700% by 2020, according to The Hemp Business Journal, as reported by Forbes. ”In 2015, the market for consumer sales of hemp-derived CBD products was $90 million.”
CBD – The Medicinal Benefits without the High
Industry analysts at the Brightfield Group believe the CBD industry could be a $22 billion market by 2020. ”It’s been flying under the radar but is set to explode having profound impacts on CPG and Pharma. We detail the category growth rates, leading brands, product innovation by segment, clinical trials and regulatory environment.”
CBD, which is a non-psychoactive cannabinoid found in cannabis, has seen its popularity explode over the last few years. It’s been shown to help with everything from PTSD and depression, to child epilepsy and multiple sclerosis.
With CBD, Orion Nutraceuticals is jumping into personal care products, massage oil, sports drinks, creams, sprays, and time-released CBD-sports wraps to name a few.
Better yet, the company has plans to develop a large-scale production capacity hub in Canada, which will allow it to provide high-quality CBD products to customers and partners throughout the global community.
For More Information on Orion Nutraceuticals, Click Here.
Colombia Offers the Company Significant Opportunity
Orion Nutraceuticals (CSE:ORI) also has a significant competitive advantage in the cannabis space thanks to its strategic JV partnership with FCM Global – a licensed Colombian cannabis producer and exporter. This partnership could bring in as much as $1.3 billion in gross sales potential for Orion Nutraceuticals (CSE:ORI) thanks to its 35% ownership stake.
With this, ORI has sizable exposure to Colombia, which is considered to have the world’s best environment for cannabis growth.
Orion Nutraceuticals (CSE:ORI) — Looking Ahead
Orion Nutraceuticals (CSE:ORI) is well-positioned to capitalize on a multi-billion-dollar CBD market where demand is just beginning to pick up steam. Plus, its exposure to the Colombian cannabis market gives it significant market advantage.
MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news.
MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com) and Orion Nutraceuticals Inc., Winning Media has been paid $100,000 for advertising and marketing services for Orion Nutraceuticals. We own ZERO shares of Orion Nutraceuticals Inc. Please click here for full disclaimer.
View source version on accesswire.com: